70
Participants
Start Date
April 27, 2022
Primary Completion Date
November 30, 2023
Study Completion Date
April 3, 2024
ALXN2050
Oral tablet.
Placebo
Oral tablet.
Research Site, Berlin
Research Site, Belgrade
Research Site, New Hyde Park
Research Site, Taipei
Research Site, Niš
Research Site, Philadelphia
Research Site, Milan
Research Site, Hamburg
Research Site, Bergamo
Research Site, Chapel Hill
Research Site, Madrid
Research Site, Charlotte
Research Site, Málaga
Research Site, Murcia
Research Site, Udine
Research Site, Boca Raton
Research Site, Tampa
Research Site, Port Charlotte
Research Site, Nashville
Research Site, Düsseldorf
Research Site, Lexington
Research Site, Seville
Research Site, Daegu
Research Site, Bochum
Research Site, West Chester
Research Site, Yangsan
Research Site, Milwaukee
Research Site, Pisa
Research Site, Houston
Research Site, San Antonio
Research Site, Aurora
Research Site, Napoli
Research Site, Phoenix
Research Site, Hualien City
Research Site, Portland
Research Site, Springfield
Research Site, Edmonton
Research Site, London
Research Site, Toronto
Research Site, Leipzig
Research Site, Roma
Research Site, Rome
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Taoyuan
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY